Kepivance and acute respiratory distress syndrome Patient Reports February 13, 2012



Kepivance Side Effects Report #4974997-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, clostridium colitis, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia What is  pneumonia. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.

Kepivance Side Effects Report #4993499-3
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia What is  pneumonia, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.

Kepivance Side Effects Report #4994856-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia What is  pneumonia, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.

Kepivance Side Effects Report #5019954-8
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia What is  pneumonia, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.


Kepivance Side Effects Report #5323576-9
Kepivance side effect was reported by a Physician from FRANCE on May 03, 2007. Female patient, 38 years of age, weighting 116.8 lb, was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, pericardial effusion, pericarditis, pleural effusion. Kepivance dosage: unknown. During the same period patient was treated with ENDOXAN, THYMOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Kepivance Side Effects Report #5411565-5
Kepivance side effect was reported by a Physician from FRANCE on Aug 02, 2007. Female patient, 38 years of age, weighting 116.8 lb, was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, pericardial effusion, pericarditis, pleural effusion. Kepivance dosage: unknown. During the same period patient was treated with ENDOXAN, THYMOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Kepivance Side Effects Report #5482267-4
Kepivance side effect was reported by a Physician from FRANCE on Oct 04, 2007. Female patient, 38 years of age, weighting 116.8 lb, was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, pericardial effusion, pericarditis, pleural effusion. Kepivance dosage: unknown. During the same period patient was treated with ENDOXAN, THYMOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Kepivance